Investors are suing Boston Beer Co. for misrepresenting the sales performance of its seltzer product line, which includes Angry Orchard Hard Seltzer and Truly Hard Seltzer.
At least three law firms have sued Boston Beer.
The number of lawsuits is expected to increase as law firms are now searching for potential plaintiffs to represent among Boston Beer’s investors.
Among the law firms was Robbins Geller Rudman & Dowd LLP, which said that management’s positive statements about its business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
The seltzer products performed below expectations in the quarter ending in June, prompting management to revise its sales forecast in July.
Consequently, the share price of Boston Beer stock plunged 26 percent and has continued to decline and is now down about 60 percent from its peak in April.
It now stands at $526 a share.


Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Supreme Court Signals Doubts Over Trump’s Bid to Fire Fed Governor Lisa Cook
Thailand Inflation Remains Negative for 10th Straight Month in January
California Sues Trump Administration Over Federal Authority on Sable Offshore Pipelines
Federal Judge Rules Trump Administration Unlawfully Halted EV Charger Funding
Trump Lawsuit Against JPMorgan Signals Rising Tensions Between Wall Street and the White House
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer
New York Judge Orders Redrawing of GOP-Held Congressional District
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock 



